Acute lymphoblastic leukaemia: open trials in Taiwan

• NCT06395103

  Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

  Trial Treatment · Phase 1/2 · Merck Sharp & Dohme LLC

  National Taiwan University Hospital (Site 1983), Taipei

  Registry updated 2026-10-30

• NCT07109219

  Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia

  Trial Treatment · Phase 1/2 · AstraZeneca

  Taichung · Taipei

  Registry updated 2026-10-15

• NCT07387926

  Safety and Efficacy of Asciminib in Pediatrics and Young Adults With Relapse/Refractory (r/r) Philadelphia Positive (Ph+) or ABL-class Ph-like Acute Lymphoblastic Leukemia (ALL)

  Trial Treatment · Phase 1/2 · Novartis Pharmaceuticals

  Taipei

  Registry updated 2026-10-15

• NCT06137118

  AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia

  Trial Treatment · Phase 1/2 · AstraZeneca

  Kaohsiung City · Taichung · Tainan · Taipei · Taoyuan

  Registry updated 2026-10-13

• NCT04877522

  Asciminib Roll-over Study

  Trial Treatment · Phase 4 · Novartis Pharmaceuticals

  Taoyuan

  Registry updated 2026-07-06

• NCT04988555

  A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

  Trial Treatment · Phase 1/2 · Sumitomo Pharma America, Inc.

  Taichung Veterans General Hospital, Taichung · National Cheng Kung University Hospital, Tainan · National Taiwan University Hospital, Taipei

  Registry updated 2026-03-24

• NCT07066397

  A Phase 1 Study of FIT-CD19-CAR-T Cells in R/R B-ALL

  Trial Treatment · Phase 1 · TriArm Therapeutics (Taiwan) Limited

  National Taiwan University Hospital, Taipei

  Registry updated 2025-07-23

All Acute lymphoblastic leukaemia trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error